HIGHLIGHTS
- who: Nadezhda Knauer et al. from the Research Institute of Fundamental and Clinical Immunology, Novosibirsk, RussiaClinic for Neurosurgery, Medical Faculty, Heinrich-Heine University Du00fcsseldorf, Du00fcsseldorf, Germany have published the article: In Vitro Validation of the Therapeutic Potential of Dendrimer-Based Nanoformulations against Tumor Stem Cells, in the Journal: (JOURNAL) of 25/01/2022
- what: In the project the authors aim to reassess the role of Lyn in glioma by benchmarking its function as a druggable therapeutic in three-dimensional disease models recapitulating the spectra of transcriptional subtypes of glioblastoma and different prominent brain cancer DNA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.